| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Pulmonary and Critical Care Medicine Section, University of Nebraska Medical Center, Omaha 68198-5125; 3 Veterans Affairs Medical Center, Omaha, Nebraska 68105; 2 University of Milan, Milan 20122, Italy; 4 First Department of Pathology, Nippon Medical School, Tokyo 113-0022; and 5 Third Department of Internal Medicine, University of Tokushima, Tokushima 770-8503, Japan
Fibroblasts are the major source of extracellular connective
tissue matrix, and the recruitment, accumulation, and stimulation of
these cells are thought to play important roles in both normal healing
and the development of fibrosis. Prostaglandin E2
(PGE2) can inhibit this process by blocking fibroblast
proliferation and collagen production. The aim of this study was to
investigate the inhibitory effect of PGE2 on human plasma
fibronectin (hFN)- and bovine bronchial epithelial cell-conditioned
medium (BBEC-CM)-induced chemotaxis of human fetal lung fibroblasts
(HFL1). Using the Boyden blind well chamber technique, PGE2
(10
7 M) inhibited chemotaxis to hFN 40.8 ± 5.3%
(P < 0.05) and to BBEC-CM 49.7 ± 11.7%
(P < 0.05). Checkerboard analysis demonstrated inhibition of both chemotaxis and chemokinesis. The effect of PGE2 was concentration dependent, and the inhibitory effect
diminished with time. Other agents that increased fibroblast cAMP
levels, including isoproterenol (105 M), dibutyryl cAMP
(105 M), and forskolin (3 × 105 M)
had similar effects and inhibited chemotaxis 54.1, 95.3, and 87.0%,
respectively. The inhibitory effect of PGE2 on HFL1 cell chemotaxis was inhibited by the cAMP-dependent protein kinase (PKA)
inhibitor KT-5720, which suggests a cAMP-dependent effect mediated by
PKA. In summary, PGE2 appears to inhibit fibroblast chemotaxis, perhaps by modulating the rate of fibroblast migration. Such an effect may contribute to regulation of the wound healing response after injury.
eicosanoids; adenosine 3',5'-cyclic monophosphate; fibronectin; fibrosis; repair
This article has been cited by other articles:
|
|
 |
|
  R. L. Sagana, M. Yan, A. M. Cornett, J. L. Tsui, D. A. Stephenson, S. K. Huang, B. B. Moore, M. N. Ballinger, J. Melonakos, C. D. Kontos, et al. Phosphatase and Tensin Homologue on Chromosome 10 (PTEN) Directs Prostaglandin E2-mediated Fibroblast Responses via Regulation of E Prostanoid 2 Receptor Expression J. Biol. Chem., November 20, 2009; 284(47): 32264 - 32271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Coward, K. Watts, C. A. Feghali-Bostwick, A. Knox, and L. Pang Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary Fibrosis Mol. Cell. Biol., August 1, 2009; 29(15): 4325 - 4339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Togo, X. Liu, X. Wang, H. Sugiura, K. Kamio, S. Kawasaki, T. Kobayashi, R. F. Ertl, Y. Ahn, O. Holz, et al. PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L959 - L969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hashimoto, X. Wang, L. Mao, T. Kobayashi, S. Kawasaki, N. Mori, M. L. Toews, H. J. Kim, D. R. Cerutis, X. Liu, et al. Sphingosine 1-Phosphate Potentiates Human Lung Fibroblast Chemotaxis through the S1P2 Receptor Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 356 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kamio, T. Sato, X. Liu, H. Sugiura, S. Togo, T. Kobayashi, S. Kawasaki, X. Wang, L. Mao, Y. Ahn, et al. Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1226 - L1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Huang, S. H. Wettlaufer, C. M. Hogaboam, K. R. Flaherty, F. J. Martinez, J. L. Myers, T. V. Colby, W. D. Travis, G. B. Toews, and M. Peters-Golden Variable Prostaglandin E2 Resistance in Fibroblasts from Patients with Usual Interstitial Pneumonia Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 66 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gillibert-Duplantier, V. Neaud, J.-F. Blanc, P. Bioulac-Sage, and J. Rosenbaum Thrombin inhibits migration of human hepatic myofibroblasts Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G128 - G136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Huang, S. H. Wettlaufer, C. Hogaboam, D. M. Aronoff, and M. Peters-Golden Prostaglandin E2 inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L405 - L413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Meng, S. Ceryak, Z. Aratsu, L. Jones, L. Epstein, and B. Bouscarel Biphasic regulation by bile acids of dermal fibroblast proliferation through regulation of cAMP production and COX-2 expression level Am J Physiol Cell Physiol, September 1, 2006; 291(3): C546 - C554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Lovgren, L. A. Jania, J. M. Hartney, K. K. Parsons, L. P. Audoly, G. A. FitzGerald, S. L. Tilley, and B. H. Koller COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, August 1, 2006; 291(2): L144 - L156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Molina-Molina, A Serrano-Mollar, O Bulbena, L Fernandez-Zabalegui, D Closa, A Marin-Arguedas, A Torrego, J Mullol, C Picado, and A Xaubet Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis Thorax, July 1, 2006; 61(7): 604 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Portnoy, T. Pan, C. A. Dinarello, J. M. Shannon, J. Y. Westcott, L. Zhang, and R. J. Mason Alveolar type II cells inhibit fibroblast proliferation: role of IL-1{alpha} Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L307 - L316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Pullar and R. R. Isseroff Cyclic AMP mediates keratinocyte directional migration in an electric field J. Cell Sci., May 1, 2005; 118(9): 2023 - 2034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sokolova, Z. Grishina, F. Buhling, T. Welte, and G. Reiser Protease-activated receptor-1 in human lung fibroblasts mediates a negative feedback downregulation via prostaglandin E2 Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L793 - L802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Branski, V. C. Sandulache, J. E. Dohar, and P. A. Hebda Mucosal Wound Healing in a Rabbit Model of Subglottic Stenosis: Biochemical Analysis of Secretions Arch Otolaryngol Head Neck Surg, February 1, 2005; 131(2): 153 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. White, R. G. Atrasz, E. G. Dickie, D. M. Aronoff, V. Stambolic, T. W. Mak, B. B. Moore, and M. Peters-Golden Prostaglandin E2 Inhibits Fibroblast Migration by E-Prostanoid 2 Receptor-Mediated Increase in PTEN Activity Am. J. Respir. Cell Mol. Biol., February 1, 2005; 32(2): 135 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Green, R. A. Stockton, C. Johnson, and B. S. Jacobson 5-Lipoxygenase and cyclooxygenase regulate wound closure in NIH/3T3 fibroblast monolayers Am J Physiol Cell Physiol, August 1, 2004; 287(2): C373 - C383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Peters-Golden When Defenses against Fibroproliferation Fail: Spotlight on an Axis of Prophylaxis Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1141 - 1142. [Full Text] [PDF]
|
|
|
|
|
|
E. A. Goncharova, C. K. Billington, C. Irani, A. V. Vorotnikov, V. A. Tkachuk, R. B. Penn, V. P. Krymskaya, and R. A. Panettieri Jr. Cyclic AMP-Mobilizing Agents and Glucocorticoids Modulate Human Smooth Muscle Cell Migration Am. J. Respir. Cell Mol. Biol., July 1, 2003; 29(1): 19 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Carlin, M. Roth, and J. L. Black Urokinase potentiates PDGF-induced chemotaxis of human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1020 - L1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Lama, B. B. Moore, P. Christensen, G. B. Toews, and M. Peters-Golden Prostaglandin E2 Synthesis and Suppression of Fibroblast Proliferation by Alveolar Epithelial Cells Is Cyclooxygenase-2-Dependent Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 752 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kohyama, T. A. Wyatt, X. Liu, F.-Q. Wen, T. Kobayashi, Q. Fang, H. J. Kim, and S. I. Rennard PGD2 Modulates Fibroblast-Mediated Native Collagen Gel Contraction Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 375 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Parameswaran, G. Cox, K. Radford, L. J. Janssen, R. Sehmi, and P. M. O'Byrne Cysteinyl Leukotrienes Promote Human Airway Smooth Muscle Migration Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 738 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kohyama, X. Liu, H. J. Kim, T. Kobayashi, R. F. Ertl, F.-Q. Wen, H. Takizawa, and S. I. Rennard Prostacyclin analogs inhibit fibroblast migration Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L428 - L432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kohyama, X. Liu, F.-Q. Wen, Y. K. Zhu, H. Wang, H. J. Kim, H. Takizawa, L. B. Cieslinski, M. S. Barnette, and S. I. Rennard PDE4 Inhibitors Attenuate Fibroblast Chemotaxis and Contraction of Native Collagen Gels Am. J. Respir. Cell Mol. Biol., June 1, 2002; 26(6): 694 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J A Pickrell and F W Oehme Invited response to definition of hormesis (EJ Calabrese and LA Baldwin) Human and Experimental Toxicology, February 1, 2002; 21(2): 107 - 109. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
